Gladstone in the News
The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.
This month, the Gladstone Institutes in San Francisco reported a chemical trick that substantially increases the efficiency of gene editing using CRISPR technology.
A new paper in the Journal of Neuroscience from scientists at the Gladstone Institutes and the University of California, San Francisco describes how manipulating levels of a protein associated with memory can stave off Alzheimer’s symptoms, even in the presence of the disease-causing toxins.
It’s been over a year since The FDA approved Truvada, a once a day medication that prevents HIV infection. But why are so few people taking it? Dr. Robert Grant talks about the drug and why it’s slow to catch on.
Blocking a pathway that plays a critical role in cleaving memories could halt memory loss in Alzheimer's disease patients, according to scientists at the Gladstone Institutes.
San Francisco was ground zero for HIV in the U.S. Now it wants to be the first city in the world with no new infections, no stigma, and no death. Drs. Warner Greene and Robert Grant are using basic science research to help the city reach its goal.
Dr. Deepak Srivastava discusses the exciting potential of using our bodies' own cells to regenerate damaged tissue. This is especially critical for creating new heart muscle from support cells after a heart attack.
Deepak Srivastava writes about how by helping cells switch their type, we may have discovered a new way to repair damaged hearts, and potentially revolutionize the future of medicine.
A supplement that scientists describe as the precursor to vitamin B3 may help prevent and treat noise-induced hearing loss, researchers at the Gladstone Institutes and Weill Cornell Medical College have found.
Dr. Lennart Mucke joins a panel of experts to discuss recent developments in Alzheimer's disease and where we are in the search for a cure.
After years of setbacks, Alzheimer's researchers are sounding optimistic again. The reason: a brain protein called tau.